Cargando…
Clinical potential of eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
Diarrhea-predominant irritable bowel syndrome (IBS-D) belongs to the group of functional gastrointestinal disorders and is characterized by abdominal pain in conjunction with diarrhea. The incidence of IBS-D is currently increasing, leading to a heavy economic burden for patients and health care sys...
Autores principales: | Sobolewska-Włodarczyk, Aleksandra, Włodarczyk, Marcin, Storr, Martin, Fichna, Jakub |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4874728/ https://www.ncbi.nlm.nih.gov/pubmed/27257381 http://dx.doi.org/10.2147/TCRM.S83722 |
Ejemplares similares
-
Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome
por: Özdener, Ayşe Elif, et al.
Publicado: (2017) -
Safety of Eluxadoline in Patients with Irritable Bowel Syndrome with Diarrhea
por: Cash, Brooks D, et al.
Publicado: (2017) -
Spotlight on eluxadoline for the treatment of patients with irritable bowel syndrome with diarrhea
por: Fragkos, Konstantinos C
Publicado: (2017) -
Targeting Histamine Receptors in Irritable Bowel Syndrome: A Critical Appraisal
por: Fabisiak, Adam, et al.
Publicado: (2017) -
Update on Eluxadoline for the Treatment of Irritable Bowel Syndrome with Diarrhea: Patient Selection and Perspectives
por: Liu, Rebecca, et al.
Publicado: (2020)